CN1409702A - 不对称合成Casodex、其衍生物及其中间体的对映体的方法 - Google Patents

不对称合成Casodex、其衍生物及其中间体的对映体的方法 Download PDF

Info

Publication number
CN1409702A
CN1409702A CN00817022A CN00817022A CN1409702A CN 1409702 A CN1409702 A CN 1409702A CN 00817022 A CN00817022 A CN 00817022A CN 00817022 A CN00817022 A CN 00817022A CN 1409702 A CN1409702 A CN 1409702A
Authority
CN
China
Prior art keywords
formula
compound
alkyl
carbon atoms
reach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00817022A
Other languages
English (en)
Chinese (zh)
Inventor
N·埃克乌里贝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nobex Corp
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of CN1409702A publication Critical patent/CN1409702A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CN00817022A 1999-10-19 2000-10-18 不对称合成Casodex、其衍生物及其中间体的对映体的方法 Pending CN1409702A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16041299P 1999-10-19 1999-10-19
US60/160,412 1999-10-19

Publications (1)

Publication Number Publication Date
CN1409702A true CN1409702A (zh) 2003-04-09

Family

ID=22576803

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00817022A Pending CN1409702A (zh) 1999-10-19 2000-10-18 不对称合成Casodex、其衍生物及其中间体的对映体的方法

Country Status (18)

Country Link
US (2) US6583306B1 (cg-RX-API-DMAC7.html)
EP (1) EP1222165A2 (cg-RX-API-DMAC7.html)
JP (1) JP5112583B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020091047A (cg-RX-API-DMAC7.html)
CN (1) CN1409702A (cg-RX-API-DMAC7.html)
AU (1) AU1968601A (cg-RX-API-DMAC7.html)
BR (1) BR0014889A (cg-RX-API-DMAC7.html)
CA (1) CA2387570A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20021340A3 (cg-RX-API-DMAC7.html)
HK (1) HK1048298A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0203785A2 (cg-RX-API-DMAC7.html)
IL (2) IL149056A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02003884A (cg-RX-API-DMAC7.html)
NO (1) NO20021831L (cg-RX-API-DMAC7.html)
NZ (1) NZ518392A (cg-RX-API-DMAC7.html)
PL (1) PL354620A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001028990A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200202947B (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US7759520B2 (en) 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6995284B2 (en) 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US6998500B2 (en) 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8008348B2 (en) 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US6838484B2 (en) 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7026500B2 (en) 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US6737550B2 (en) * 2001-06-13 2004-05-18 Biogal Gryogyszergyar Rt. Process for preparing rac-bicalutamide and its intermediates
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
PT1463497E (pt) 2001-12-06 2011-12-20 Gtx Inc Tratamento do desgaste muscular com moduladores selectivos do receptor de androgénios
US6740770B2 (en) 2001-12-13 2004-05-25 Sumika Fine Chemicals Co., Ltd. Crystal of bicalutamide and production method thereof
CA2689080C (en) 2002-02-07 2011-07-05 University Of Tennessee Research Foundation Treating benign prostate hyperplasia with sarms
JP5113979B2 (ja) 2002-02-28 2013-01-09 ユニバーシティ オブ テネシー リサーチ ファウンデーション 複数置換の選択的アンドロゲンレセプタ修飾因子及びその使用方法
US7772433B2 (en) 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
WO2003074450A2 (en) 2002-02-28 2003-09-12 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
US7803970B2 (en) 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
DE10222104A1 (de) 2002-05-17 2003-12-04 Helm Ag Verfahren zur Herstellung von N-(4'-Cyano-3'-trifluormethyl)-3-(4"-fluorphenylsulfonyl)-2-hydroxy-2-methylpropionamid
US7741371B2 (en) 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
AU2003241583B2 (en) 2002-06-17 2009-05-21 University Of Tennessee Research Foundation N-bridged selective androgen receptor modulators and methods of use thereof
DE50213170D1 (de) * 2002-09-04 2009-02-12 Fraunhofer Ges Forschung Verwendung eines Mittel zur Therapie der Herzhypertrophie
US20040063782A1 (en) * 2002-09-27 2004-04-01 Westheim Raymond J.H. Bicalutamide forms
US6818766B2 (en) 2002-10-02 2004-11-16 Synthon Bv Process for making bicalutamide and intermediates thereof
EP1562594A4 (en) 2002-10-15 2008-12-17 Univ Tennessee Res Foundation SELECTIVE ANDROGEN RECEPTOR MODULATORS WITH METHYLENE BRIDGES AND METHOD OF USE THEREOF
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
JP4322621B2 (ja) 2003-10-16 2009-09-02 住友化学株式会社 4’−シアノ−3−[(4−フルオロフェニル)スルホニル]−2−ヒドロキシ−2−メチル−3’−トリフルオロメチルプロピオンアニリドの製造方法
AU2004305061A1 (en) 2003-12-16 2005-07-07 Gtx, Inc. Prodrugs of selective androgen receptor modulators and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
WO2008013791A2 (en) * 2006-07-24 2008-01-31 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
AU2007287070C1 (en) 2006-08-24 2013-02-14 University Of Tennessee Research Foundation Substituted acylanilides and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
WO2010116342A2 (en) * 2009-04-10 2010-10-14 Consiglio Nazionale Delle Ricerche Non-steroidal compounds for androgen receptor modulation
ITBO20090236A1 (it) * 2009-04-10 2010-10-11 Consiglio Nazionale Ricerche Procedimento per la sintesi di composti per il trattamento del tumore alla prostata
WO2011008543A2 (en) * 2009-06-29 2011-01-20 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
CN103539710A (zh) * 2012-07-02 2014-01-29 国药一心制药有限公司 一种(r)-比卡鲁胺的合成方法
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
EP3733170A1 (en) 2012-07-13 2020-11-04 Oncternal Therapeutics, Inc. A method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US12685719B2 (en) 2012-07-13 2026-07-21 University Of Tennessee Research Foundation Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3372965D1 (en) 1982-07-23 1987-09-17 Ici Plc Amide derivatives
GB8617652D0 (en) 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
WO1998055153A1 (en) 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US6186674B1 (en) * 1998-09-15 2001-02-13 Lucent Technologies, Inc. Optical sub-assembly package mount
US6252762B1 (en) * 1999-04-21 2001-06-26 Telcordia Technologies, Inc. Rechargeable hybrid battery/supercapacitor system
US6331992B1 (en) * 2000-04-07 2001-12-18 Stratos Lightwave, Inc. Small format optical subassembly
US6459842B1 (en) * 2000-12-13 2002-10-01 Teraconnect, Inc. Packaging system for two-dimensional optoelectronic arrays
US6821032B2 (en) * 2002-05-28 2004-11-23 Intel Corporation Methods of sealing electronic, optical and electro-optical packages and related package and substrate designs

Also Published As

Publication number Publication date
IL149056A (en) 2011-05-31
WO2001028990A2 (en) 2001-04-26
IL149056A0 (en) 2002-11-10
NO20021831D0 (no) 2002-04-18
US6583306B1 (en) 2003-06-24
AU1968601A (en) 2001-04-30
NZ518392A (en) 2004-02-27
JP5112583B2 (ja) 2013-01-09
NO20021831L (no) 2002-06-19
US7022869B2 (en) 2006-04-04
KR20020091047A (ko) 2002-12-05
US20040030130A1 (en) 2004-02-12
HUP0203785A2 (hu) 2003-04-28
PL354620A1 (en) 2004-02-09
HK1048298A1 (zh) 2003-03-28
ZA200202947B (en) 2003-09-23
CZ20021340A3 (cs) 2002-08-14
WO2001028990A3 (en) 2001-09-07
JP2003512351A (ja) 2003-04-02
BR0014889A (pt) 2002-12-31
MXPA02003884A (es) 2004-09-06
EP1222165A2 (en) 2002-07-17
CA2387570A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
JP5112583B2 (ja) カソデックス、その誘導体およびその中間体の鏡像体を非対照的に合成する方法
TWI271397B (en) Resolution of intermediates in the synthesis of substantially enantiomerically pure bicalutamide
CN1098261C (zh) 旋光提纯对映体含量高的苯并咪唑衍生物的方法
CN1097583C (zh) 制备氟苯尼考的中间体的方法
CN1072218C (zh) 1-(巯甲基)环丙烷乙酸的制备工艺
JP4358518B2 (ja) ビカルタミドを含むアシルアニリドおよびそれらの誘導体を合成する方法
CN1059517A (zh) 乙酰胺衍生物
CN1501912A (zh) N-(取代的苯基)-3-烷基-,芳基-和杂芳基磺酰基-2-羟基-2-烷基-和卤代烷基丙酰胺化合物的制备方法
WO2001000608A1 (en) Process for the synthesis of n-(4-cyano-3-trifluoromethylphenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide
CN1423643A (zh) 制备5-氰基2-苯并[c]呋喃酮的方法
CN1168878A (zh) 制备旋光2-卤代-3-羟基丙酸酯的方法
JP2005530795A (ja) ビカルタミドの製造方法
CN1283612C (zh) 4-苯基-4-氧代-2-丁烯酸酯衍生物的制造方法
CN1255121A (zh) 制备药用化合物的选择性环氧化的方法
CN1104641A (zh) 制备n-叔丁基酰胺的方法
CN1192017C (zh) 环己烷羧酸的制备方法
JPH0597823A (ja) トランスー(5r)−2,4,5−トリ置換2−オキサゾリンの製造方法
RU2414464C2 (ru) Способ получения n-[3-[(2-метоксифенил)сульфанил]-2-метилпропил]-3,4-дигидро-2н-1,5-бензоксатиепин-3-амина
JP2008534575A (ja) ビカルタミドの調製のための新規プロセス
EP0403250B1 (en) Phenylglycidamides useful for preparing alpha-hydroxy-beta-sulfido-arylpropionic acid derivatives
JP3828197B2 (ja) 光学活性3−(p−メトキシフェニル)グリシッド酸アルカリ金属塩の製造法
CN1252058A (zh) 丁硫基-异喹啉的制备方法及其中间体
JP3864672B2 (ja) エリスロ−3−アミノ−2−ヒドロキシ酪酸誘導体の製造法
JPWO2004065368A1 (ja) トランドラプリル合成中間体の製造方法
KR20010013668A (ko) 광학 활성 페닐옥시란 화합물의 제조방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication